Participate in a Research Study Involving ketamine

If you considering initiating ketamine therapy for depression, then you may be eligible to participate at IV Solution in a UIC, Baylor research study involving ketamine with a novel digital therapy that can enhance or prolong the effects of IV ketamine on depression:

• You will complete digital therapy exercises remotely at 3 points over a 4-5 month period, as well as remote interviews and questionnaires to measure symptoms over about a year.

• You will be compensated $650 at the conclusion of the study.

Contact us now at info@chicagoivsolution.com to see if you qualify while spots are available!